![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
R Testa, L Guarneri, C Taddei, E Poggesi, P Angelico, A Sartani, A Leonardi, ON Gofrit, S Meretyk and M Caine
Pharmaceutical R&D Division, Recordati S.p.A., Milano, Italy.
The aim of this study was to compare with known reference standards the functional in vitro alpha-1 antagonistic activity of Rec 15/2739 on noradrenaline-induced contractions of human prostate and mesenteric artery. We also characterized these tissues with regard to the alpha-1 adrenoceptor subtypes present. Comparing the apparent pKB values revealed Rec 15/2739 to be one of the most potent compounds action on the prostate. Its potency was slightly lower than that of tamsulosin and was higher than the potencies of prazosin, terazosin and 5- methylurapidil. On the mesenteric artery, tamsulosin was the most potent compound. Comparing the results from the functional studies with those obtained from radioreceptor binding studies, we found that the potency (pKB value) in inhibiting the contraction of prostatic tissue showed a close and significant correlation with the affinity for native and recombinant alpha-1A adrenoceptors. No significant correlation was found with affinity for either the native or the recombinant alpha-1B adrenoceptor subtype, or for recombinant alpha-1d receptors. Similar results were obtained for mesenteric artery. In order to characterize further the alpha-1 adrenoceptor subtypes present in the examined tissues, we investigated the functional effects of chloroethylclonidine, an alpha-1B-D subtypes selective alpha-1 adrenoceptor irreversible antagonist, and those of nifedipine, which antagonizes the extracellular calcium influx primarily mediated by alpha-1A adrenoceptor stimulation. The results indicate the presence of both chloroethylclonidine-sensitive and -insensitive alpha-1 adrenoceptor subtypes in the human prostate, whereas in mesenteric artery the alpha-1A subtype seems to be present exclusively. The possibility that the functionally relevant alpha-1 adrenoceptor subtype could be classified as alpha-1L in both tissues shoul also be considered.
This article has been cited by other articles:
|
|
 |
|
  M. T.C.C. Patrao, D. B.C. Queiroz, G. Grossman, P. Petrusz, M. d. F. M. Lazari, and M. C. W. Avellar Cloning, expression and immunolocalization of {alpha}1-adrenoceptor in different tissues from rhesus monkey and human male reproductive tract Mol. Hum. Reprod., February 1, 2008; 14(2): 85 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B.C. Queiroz, F. R. Mendes, C. S. Porto, and M. C. W. Avellar {alpha}1-Adrenoceptor Subtypes in Rat Epididymis and the Effects of Sexual Maturation Biol Reprod, February 1, 2002; 66(2): 508 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. Pulito, X. Li, S. S. Varga, L. S. Mulcahy, K. S. Clark, S. A. Halbert, A. B. Reitz, W. V. Murray, and L. K. Jolliffe An Investigation of the Uroselective Properties of Four Novel alpha 1a-Adrenergic Receptor Subtype-Selective Antagonists J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 224 - 229. [Abstract] [Full Text]
|
|
|
|
 |
|
 X. L. Rudner, D. E. Berkowitz, J. V. Booth, B. L. Funk, K. L. Cozart, E. B. D’Amico, H. El-Moalem, S. O. Page, C. D. Richardson, B. Winters, et al. Subtype Specific Regulation of Human Vascular {alpha}1-Adrenergic Receptors by Vessel Bed and Age Circulation, December 7, 1999; 100(23): 2336 - 2343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Daniel, R. D. Brown, Y. F. Wang, A. M. Low, H. Lu-Chao, and C.-Y. Kwan alpha -Adrenoceptors in Canine Mesenteric Artery Are Predominantly 1A Subtype: Pharmacological and Immunochemical Evidence J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 671 - 679. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Low, H. Lu-Chao, Y. F. Wang, R. D. Brown, C. Y. Kwan, and E. E. Daniel Pharmacological and Immunocytochemical Characterization of Subtypes of Alpha-1 Adrenoceptors in Dog Aorta J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 894 - 901. [Abstract] [Full Text]
|
|
|
|
|
|
D. J. Martin, P. Lluel, E. Guillot, A. Coste, D. Jammes, and I. Angel Comparative Alpha-1 Adrenoceptor Subtype Selectivity and Functional Uroselectivity of Alpha-1 Adrenoceptor Antagonists J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 228 - 235. [Abstract] [Full Text]
|
|
|
|
|
|
A. Leonardi, J. P. Hieble, L. Guarneri, D. P. Naselsky, E. Poggesi, G. Sironi, A. C. Sulpizio, and R. Testa J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1272 - 1283. [Abstract] [Full Text]
|
|
|
|
|
|
R. Testa, L. Guarneri, P. Angelico, E. Poggesi, C. Taddei, G. Sironi, D. Colombo, A. C. Sulpizio, D. P. Naselsky, J. P. Hieble, et al. J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1284 - 1293. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
